Skip to search formSkip to main contentSkip to account menu

BETA-N-ACETYLHEXOSAMINIDASE

Known as: beta N Acetyl hexosaminidase, N-Acetyl-beta-D-hexosaminidase, beta N Acetylhexosaminidases 
A hexosaminidase specific for non-reducing N-acetyl-D-hexosamine residues in N-acetyl-beta-D-hexosaminides. It acts on GLUCOSIDES; GALACTOSIDES; and… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1997
Highly Cited
1997
Tay-Sachs and Sandhoff diseases are autosomal recessive neurodegenerative diseases resulting from the inability to catabolize GM2… 
Highly Cited
1983
Highly Cited
1983
Recent work from several laboratories has suggested the participation of intermediate structures in the delivery of adsorbed… 
Highly Cited
1982
Highly Cited
1982
The lysosomal degradation of ganglioside GM2 by hexosaminidase A depends on the presence of the specific activator protein which… 
Highly Cited
1981
Highly Cited
1981
Hexosaminidase deficiency diseases or Gm2-gangliosidoses were originally described as infantile encephalopathies. Recently… 
Highly Cited
1979
Highly Cited
1979
The activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A was purified some 2 500-fold from normal… 
Highly Cited
1976
Highly Cited
1976
An activator stimulating the enzymic hydrolysis of sphingoglycolipids has been purified from human liver. The purity of the… 
Highly Cited
1975
Highly Cited
1975
The beige mouse is an animal model for the human Chediak-Higashi syndrome, a disease characterized by giant lysosomes in most…